A detailed history of Avantax Advisory Services, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 84,412 shares of AMGN stock, worth $24.8 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
84,412
Previous 81,997 2.95%
Holding current value
$24.8 Million
Previous $25.6 Million 6.16%
% of portfolio
0.18%
Previous 0.19%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $747,152 - $814,772
2,415 Added 2.95%
84,412 $27.2 Million
Q2 2024

Aug 09, 2024

BUY
$262.75 - $319.31 $5.37 Million - $6.53 Million
20,453 Added 33.23%
81,997 $25.6 Million
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $1.5 Million - $1.81 Million
5,580 Added 9.97%
61,544 $17.5 Million
Q4 2023

Feb 07, 2024

BUY
$255.7 - $288.46 $940,976 - $1.06 Million
3,680 Added 7.04%
55,964 $16.1 Million
Q3 2023

Nov 07, 2023

BUY
$218.65 - $271.46 $1.72 Million - $2.14 Million
7,868 Added 17.71%
52,284 $14.1 Million
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $589,671 - $697,274
2,752 Added 6.61%
44,416 $9.86 Million
Q1 2023

Apr 28, 2023

BUY
$225.79 - $275.2 $1.6 Million - $1.95 Million
7,084 Added 20.49%
41,664 $10.1 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $86,344 - $109,710
-377 Reduced 1.08%
34,580 $9.08 Million
Q3 2022

Nov 01, 2022

BUY
$224.46 - $253.15 $443,981 - $500,730
1,978 Added 6.0%
34,957 $7.88 Million
Q2 2022

Aug 02, 2022

BUY
$230.71 - $256.74 $379,979 - $422,850
1,647 Added 5.26%
32,979 $8.02 Million
Q1 2022

Apr 27, 2022

BUY
$219.27 - $242.57 $250,844 - $277,500
1,144 Added 3.79%
31,332 $7.57 Million
Q4 2021

Jan 24, 2022

BUY
$198.88 - $227.6 $121,913 - $139,518
613 Added 2.07%
30,188 $6.79 Million
Q3 2021

Oct 21, 2021

BUY
$212.27 - $248.7 $743,157 - $870,698
3,501 Added 13.43%
29,575 $6.29 Million
Q2 2021

Jul 29, 2021

BUY
$233.58 - $259.14 $187,798 - $208,348
804 Added 3.18%
26,074 $6.35 Million
Q1 2021

May 13, 2021

BUY
$221.91 - $258.6 $327,982 - $382,210
1,478 Added 6.21%
25,270 $6.27 Million
Q4 2020

Jan 22, 2021

SELL
$216.38 - $257.67 $2.07 Million - $2.46 Million
-9,552 Reduced 28.65%
23,792 $5.47 Million
Q3 2020

Oct 14, 2020

BUY
$234.65 - $260.95 $2.27 Million - $2.53 Million
9,689 Added 40.96%
33,344 $8.48 Million
Q2 2020

Aug 06, 2020

BUY
$197.81 - $242.74 $96,926 - $118,942
490 Added 2.12%
23,655 $5.59 Million
Q1 2020

Apr 30, 2020

BUY
$182.24 - $241.7 $181,328 - $240,491
995 Added 4.49%
23,165 $4.7 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $944,914 - $1.21 Million
4,994 Added 29.08%
22,170 $5.34 Million
Q3 2019

Nov 08, 2019

BUY
$174.11 - $208.62 $82,528 - $98,885
474 Added 2.84%
17,176 $3.32 Million
Q2 2019

Aug 06, 2019

BUY
$166.7 - $195.41 $297,059 - $348,220
1,782 Added 11.94%
16,702 $3.08 Million
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $20,980 - $23,650
-116 Reduced 0.77%
14,920 $2.84 Million
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $2.68 Million - $3.13 Million
15,036 New
15,036 $2.93 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.